Michal Entin‐Meer

Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas

Michal Entin‐Meer, Ada Rephaeli, Xiaodong Yang et al. · Molecular Cancer Therapeutics · 2005 · 82 citations

Pathology, High-grade Gliomas, Cancer Biology +16

Experimental Myocardial Infarction Induces Altered Regulatory T Cell Hemostasis, and Adoptive Transfer Attenuates Subsequent Remodeling

Rinat Sharir, Jonathan Semo, Sara Shimoni et al. · PLoS ONE · 2014 · 75 citations · Full text

Characterization of structurally distinct, isoform-selective phosphoinositide 3′-kinase inhibitors in combination with radiation in the treatment of glioblastoma

Jack S. Chen, Linda J. Zhou, Michal Entin‐Meer et al. · Molecular Cancer Therapeutics · 2008 · 63 citations

Pi3k Inhibitors, High-grade Gliomas, Tumor Growth Rate +18

In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas1

Michal Entin‐Meer, Xiaodong Yang, Scott R. VandenBerg et al. · Neuro-Oncology · 2007 · 53 citations · Full text

Neuro-oncology, Oncology, Radiation Therapy +15

TRPV2 knockout mice demonstrate an improved cardiac performance following myocardial infarction due to attenuated activity of peri-infarct macrophages

Michal Entin‐Meer, Lena Cohen, Einat Hertzberg-Bigelman et al. · PLoS ONE · 2017 · 49 citations · Full text